Neurotrophic Keratitis
📧 Sign up to get email alerts when something new happens for Neurotrophic Keratitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of STSP-0902 ophthalmic solution in healthy volunteers has been completed for neurotr…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: DEFENDO Long Term Follow-up Study in Stage 1 NK Patients
The DEFENDO long-term follow-up study in Stage 1 Neurotrophic Keratitis patients has completed enrollment and posted results on 2025-11-28.
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of ZKY001 Eye Drops for corneal epithelial defects caused by neurotrophic kerati…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients [Phase 2]
A Phase 2 clinical trial by Recordati Group evaluating investigational eye drops for moderate to severe Neurotrophic keratitis in adults has…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Corneal Nerves After Treatment With Cenegermin
This clinical trial update reports on corneal nerve outcomes after treatment with cenegermin in neurotrophic keratitis, and the study status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis [Phase 2]
Phase 2 clinical trial update evaluating the initial efficacy and safety of BRM424 ophthalmic solution in neurotrophic keratitis; the study …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects [Phase 1, Phase 2]
A Phase 1/2 study evaluating the safety and efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis [Phase 4]
Phase 4 clinical trial evaluating OXERVATE (cenegermin) for stage 1 neurotrophic keratitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer [Phase 3]
Phase 3 trial comparing T4020 to vehicle in chronic neurotrophic keratitis or corneal ulcer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. [Phase 1, Phase 2]
Clinical trial evaluating safety and efficacy of rhNGF in stage 2–3 neurotrophic keratitis completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK [Phase 2]
Phase 2 trial evaluating the efficacy of a new formulation of rhNGF at 20 µg/ml with antioxidant in Neurotrophic Keratitis completed (result…